YARDLEY, Pa., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the appointment of Terry Kohler as Chief Financial Officer.
Optinose Appoints Terry Kohler as Chief Financial Officer
OPTINOSE INC
NASDAQ:OPTN (2/11/2025, 3:40:54 PM)
5.6
-0.1 (-1.75%)
OPTN Latest News and Analysis
a day ago - ChartmillMonday's pre-market session: top gainers and losersDiscover the top movers in Monday's pre-market session and stay informed about market dynamics.
